ReViVox: The Drug That Could Reverse Botox
The first thing I always explain to my patients at a Botox appointment is that while its effects are temporary, it is not reversibile, which is why careful placement and an experienced medical clinician is very important to minimise the risk of complications. Historically, we’ve never been able to reverse the effects of Botox, unlike filler which can be dissolved.
However, a new drug ReViVox, may soon change all that, and make Botox reversible in the future!
Let’s find out more.
What is ReViVox?
DelNova's ReViVox stands out as a potentially groundbreaking innovation in the world of medical aesthetics. This novel drug addresses the critical gap in managing adverse effects associated with botulinum toxin. Until now, patients and clinicians alike have had no commercially available option to reverse these effects, leaving a significant need unmet in the market.
ReViVox is an anticholinesterase agent, a compound with a long-standing history in reversing neuromuscular blockade in anaesthesia. However, unlike its intravenous application in anaesthesia, ReViVox is administered locally to the affected muscle area.
A Pioneering Clinical Study
The efficacy of ReViVox was demonstrated in a proof-of-concept study spearheaded by Dr. Steve Yoelin, a board-certified ophthalmologists. The study, which showcased rapid recovery of muscle movement within just 5 minutes post-treatment, represents a first in human trials.
This was presented at the prestigious 17th Annual Botulinum Research Symposium, marking a milestone in aesthetic medicine. The study utilised a validated photo-numeric scale to assess the recovery, ensuring objective and reliable results.
Transforming Patient Experience in Medical Aesthetics
ReViVox is poised to revolutionise the patient experience in neurotoxin treatments. Its ability to swiftly counteract unwanted effects enables healthcare providers to administer neurotoxins more confidently. For patients, it means peace of mind, knowing that any undesirable outcomes from aesthetic procedures can be promptly and effectively remedied. This enhances the overall safety and satisfaction associated with neurotoxin treatments, significantly reducing anxiety related to potential side effects.
Final Thoughts
While there has only been one pilot study conducted so far, ReViVox represents a significant advancement in aesthetic medicine. In the future, it may be able to offer rapid, safe, and effective relief from the side effects of Botox treatments. While further research is needed, it is an exciting development in the world of aesthetics!
See our summary slides below:
Galderma has unveiled Relfydess™ (RelabotulinumtoxinA), the world’s first ready-to-use liquid neuromodulator developed with proprietary PEARL™ Technology. This groundbreaking product has recently received approval for use in Europe. So what is it, and what sets it apart from the other toxins?.